The high expression of PDE4D has been reported to be associated with aggressive disease in multiple cancers, with therapeutic potential reported for pancreatic ductal adenocarcinoma [48], tamoxifen-resistant ER-positive breast cancer [49], lung cancer [50] and colon cancer [51]. This evidence concerns the gene PDE4D and lung carcinoma.